Neutronic characteristics of linear-assembly breed-and-burn reactorsPETROSKI, Robert; FORGET, Benoit; FORSBERG, Charles et al.Nuclear engineering and design. 2012, Vol 250, pp 364-384, issn 0029-5493, 21 p.Article

USING THE NEUTRON EXCESS CONCEPT TO DETERMINE STARTING FUEL REQUIREMENTS FOR MINIMUM BURNUP BREED-AND-BURN REACTORSPETROSKI, Robert; FORGET, Benoit; FORSBERG, Charles et al.Nuclear technology. 2011, Vol 175, Num 2, pp 388-400, issn 0029-5450, 13 p.Article

Thermal hydraulic design of a liquid salt-cooled flexible conversion ratio fast reactor : Flexible Conversation Fast ReactorsPETROSKI, Robert; HEJZLAR, Pavel; TODREAS, Neil E et al.Nuclear engineering and design. 2009, Vol 239, Num 12, pp 2612-2625, issn 0029-5493, 14 p.Article

Innovations in the ENHS reactor design and fuel cycleGREENSPAN, Ehud; SER GI HONG; KI BOG LEE et al.Progress in nuclear energy (New series). 2008, Vol 50, Num 2-6, pp 129-139, issn 0149-1970, 11 p.Conference Paper

Cross-comparison of fast reactor concepts with various coolants : Flexible Conversation Fast ReactorsHEJZLAR, Pavel; TODREAS, Neil E; SHWAGERAUS, Eugene et al.Nuclear engineering and design. 2009, Vol 239, Num 12, pp 2672-2691, issn 0029-5493, 20 p.Article

N-[6-Amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A_2AReceptor Antagonists with Improved Drug Like Properties and in Vivo EfficacyLANIER, Marion C; MOORJANI, Manisha; MARKISON, Stacy et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 3, pp 709-717, issn 0022-2623, 9 p.Article

2-Amino-N-pyrimidin-4-ylacetamides as A_2A Receptor Antagonists: 2. Reduction of hERG Activity, Observed Species Selectivity, and Structure-Activity RelationshipsSLEE, Deborah H; MOORJANI, Manisha; JOSWIG, Tanya et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 6, pp 1730-1739, issn 0022-2623, 10 p.Article

Synthesis and structure-activity relationships of retro bis- aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1ROWBOTTOM, Martin W; VICKERS, Troy D; SCHWARZ, David et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 17, pp 4450-4457, issn 0960-894X, 8 p.Article

Pharmacological characterization of threo-3-methylglutamic acid with excitatory amino acid transporters in native and recombinant systemsELIASOF, Scott; MCILVAIN, H. Beal; PETROSKI, Robert E et al.Journal of neurochemistry. 2001, Vol 77, Num 2, pp 550-557, issn 0022-3042Article

Brain-penetrating 2-aminobenzimidazole H₁-antihistamines for the treatment of insomniaCOON, Timothy; MOREE, Wilna J; WEN, Jenny et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 15, pp 4380-4384, issn 0960-894X, 5 p.Article

Novel benzothiophene H₁-antihistamines for the treatment of insomniaMOREE, Wilna J; JOVIC, Florence; HERNANDEZ, Lisa M et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 7, pp 2316-2320, issn 0960-894X, 5 p.Article

Characterization of Novel Selective H₁-Antihistamines for Clinical Evaluation in the Treatment of InsomniaMOREE, Wilna J; LI, Bin-Feng; BRADBURY, Margaret J et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 17, pp 5307-5310, issn 0022-2623, 4 p.Article

Identification of a novel selective H₁-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomniaMOREE, Wilna J; LI, Bin-Feng; HERNANDEZ, Lisa M et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 19, pp 5874-5878, issn 0960-894X, 5 p.Article